MERSANA THERAPEUTICS
Mersana Therapeutics employs its biodegradable polymer platform to create new and better medicines. They are advancing their own clinical-stage pipeline of novel compounds with the potential to address multiple oncology indications. It was founded in 2005 and headquartered in Cambridge, Massachusetts.
MERSANA THERAPEUTICS
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2005-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.mersana.com
Total Employee:
101+
Status:
Active
Contact:
617-498-0020
Total Funding:
480.61 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Protagonist Therapeutics
Protagonist Therapeutics develops orally-stable peptides to treat diseases that are currently addressed by injectable antibodies.
Current Advisors List
Advisor
Advisor
Advisor
Board_member
2012-07-01
Board_member
2007-01-01
Advisor
Board_member
Board_member
Current Employees Featured
David R. Elmaleh Founder @ Mersana Therapeutics
Founder
Timothy B. Lowinger Chief Science & Technology Officer @ Mersana Therapeutics
Chief Science & Technology Officer
2019-08-01
Karen Hong Principal, ProQuest Investments @ Mersana Therapeutics
Principal, ProQuest Investments
K. Dane Wittrup Member, Scientific Advisory Board @ Mersana Therapeutics
Member, Scientific Advisory Board
2015-05-01
Mohan Bala SVP, Strategic Product Planning & Program Leadership @ Mersana Therapeutics
SVP, Strategic Product Planning & Program Leadership
2021-10-01
ANNA PROTOPAPAS President & CEO @ Mersana Therapeutics
President & CEO
2015-03-01
Tushar Misra Chief Manufacturing Officer @ Mersana Therapeutics
Chief Manufacturing Officer
2021-08-01
Dirk Huebner Chief Medical Officer @ Mersana Therapeutics
Chief Medical Officer
Brian DeSchuytner Chief Financial Officer @ Mersana Therapeutics
Chief Financial Officer
2021-10-01
Founder
Stock Details
Investors List
Bain Capital Life Sciences
Bain Capital Life Sciences investment in Post-IPO Equity - Mersana Therapeutics
Consonance Capital Partners
Consonance Capital Partners investment in Post-IPO Equity - Mersana Therapeutics
Avoro Capital Advisors
Avoro Capital Advisors investment in Post-IPO Equity - Mersana Therapeutics
ArrowMark Partners
ArrowMark Partners investment in Series C - Mersana Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series C - Mersana Therapeutics
Rock Springs Capital
Rock Springs Capital investment in Series C - Mersana Therapeutics
Wellington Management
Wellington Management investment in Series C - Mersana Therapeutics
New Enterprise Associates
New Enterprise Associates investment in Series C - Mersana Therapeutics
Takeda
Takeda investment in Series C - Mersana Therapeutics
F-Prime Capital
F-Prime Capital investment in Series B - Mersana Therapeutics
Key Employee Changes
Official Site Inspections
http://www.mersana.com Semrush global rank: 6.43 M Semrush visits lastest month: 1.02 K
- Host name: 204.182.199.35.bc.googleusercontent.com
- IP address: 35.199.182.204
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Mersana Therapeutics"
About Us - Mersana Therapeutics
Mersana is a biopharmaceutical company specializing in the discovery and development of antibody-drug conjugate (ADC) therapies to treat patients fighting cancer.See details»
Mersana Therapeutics - Crunchbase Company Profile …
Mersana Therapeutics employs its biodegradable polymer platform to create new and better medicines. They are advancing their own clinical-stage pipeline of …See details»
Executive Team - Mersana Therapeutics
Alejandra joined Mersana in April 2021, bringing with her 20 years of legal leadership and transformational business development experience. Before joining Mersana, Alejandra was …See details»
Presentation - Mersana Therapeutics
Mersana Therapeutics - Funding, Financials, Valuation …
Mersana Therapeutics develops a biodegradable polymer platform Fleximer® which creates new and better medicines.See details»
Mersana Therapeutics - Org Chart, Teams, Culture & Jobs | The Org
View Mersana Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Mersana Therapeutics Provides Business Update and Announces …
Mar 3, 2025 About Mersana Therapeutics Mersana Therapeutics is a clinical-stage biopharmaceutical company focused on the development of novel antibody-drug conjugates …See details»
Mersana Therapeutics Inc: Business Model, SWOT Analysis, and ...
Apr 6, 2024 Discover how Mersana Therapeutics Inc. positions itself in the biotech landscape with a comprehensive analysis of its business model, SWOT insights, and competitive …See details»
Mersana Therapeutics Inc: Overview - GlobalData
Up-to-date Mersana Therapeutics Inc company overview including funding information, company profile, key statistics, peer comparison and more.See details»
Mersana Therapeutics Announces Additional FDA Fast Track …
Jan 10, 2025 About Mersana Therapeutics Mersana Therapeutics is a clinical-stage biopharmaceutical company focused on the development of novel antibody-drug conjugates …See details»
About - Mersana Therapeutics
Mersana Therapeutics is a clinical-stage biopharmaceutical company focused on the development of novel antibody-drug conjugates (ADCs) and driven by the knowledge that patients are …See details»
Mersana Therapeutics Announces Changes in Leadership
CAMBRIDGE, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and …See details»
Mersana Therapeutics, Inc. (MRSN) - Yahoo Finance Canada
See the company profile for Mersana Therapeutics, Inc. (MRSN) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Mersana Therapeutics - Craft
Oct 28, 2024 Mersana Therapeutics is a clinical-stage biotechnology company developing antibody-drug conjugate (ADC) platforms. It engineers immunoconjugate therapies and the …See details»
ESG - Mersana Therapeutics
In 2023, Mersana became a corporate sponsor of the Science Club For Girls, Inc., a local non-profit organization focused on fostering excitement, confidence and literacy in STEM for girls …See details»
A Brief History of Mersana Therapeutics
Dec 19, 2024 Mersana Therapeutics, a leading biopharmaceutical company revolutionizing the field of oncology, has a rich and intriguing history that is worth exploring. Founded in 2001, …See details»
Mersana Therapeutics Announces Changes in Leadership
Sep 6, 2023 Mersana Therapeutics is a clinical-stage biopharmaceutical company focused on the development of novel antibody-drug conjugates (ADCs) and driven by the knowledge that …See details»
Mersana Therapeutics, Inc. (MRSN) - Yahoo Finance Canada
Jun 25, 2017 Find the latest Mersana Therapeutics, Inc. (MRSN) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Mersana Therapeutics Announces Option Agreement with GSK for …
Aug 8, 2022 Mersana has retained options to profit-share and to co-promote in the United States. If it exercises its profit-share option, Mersana will be eligible to receive tiered royalties …See details»
Patient-reported outcomes from the MIRASOL trial evaluating ...
Mar 31, 2025 JWM reports institutional research funding from Adaptimmune, Amgen, Arsenal Biosciences, ImmunoGen, Laekna Therapeutics, Merck, Mersana Therapeutics, F Hoffmann …See details»